Now Approved in the EU

(Adnkronos) – GAITHERSBURG, Md., Oct. 31, 2023 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced the European Commission has granted approval for Nuvaxovid™ XBB.1.5 dispersion